Showing 2881-2890 of 8659 results for "".
News
https://practicaldermatology.com/topics/general-topics/news/21280/The Best Asset Protection Implementation is Not Asset Protection... Is Yours?
https://practicaldermatology.com/topics/practice-management/the-best-asset-protection-implementation-is-not-asset-protection-is-yours/21472/A review of plans that will offer protection if needed and help build wealth along the way.New Products/New in My Practice: Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-devices-2/23473/Melanoma Mortality: Women Maintain the Advantage
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-mortality-women-maintain-the-advantage/20387/Global data show that men have higher rates of mortality and more rapid melanoma progression. We still don't know why.New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21235/News
https://practicaldermatology.com/topics/general-topics/news/21281/Dermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/The Excimer Laser for Psoriasis: A Review of Safety and Efficacy
https://practicaldermatology.com/topics/practice-management/the-excimer-laser-for-psoriasis-a-review-of-safety-and-efficacy/21883/Specialists describe the evolving role of the excimer laser in treating psoriasis.Update on the Treatment of Actinic Keratoses
https://practicaldermatology.com/topics/general-topics/update-on-the-treatment-of-actinic-keratoses/21630/From mainstay therapies to newly approved agents, treatment options for actinic keratoses are growing.